Research Article
Incidence, Management, and Outcome of Molar Pregnancies at a Tertiary Care Hospital in Quetta, Pakistan
Table 2
Diagnosis, management of HM, and associated complications.
| | Number of cases | % |
| (1) Diagnostic utility | | | Sonographic findings | 73 | 79.5% | hCG | 85 | 100% | Histopathology | 85 | 100% |
| (2) hCG levels (MIU/mL) | | | <50,000 | 12 | 14.1% | 50,000–100,000 | 53 | 62.4% | >100,000 | 20 | 23.5% |
| (3) Treatment modality | | | Suction/sharp curettage | 62 | 72.9% | Oxytocin/curettage | 10 | 11.8% | Hysterectomy | 12 | 14.1% | Prostaglandins/curettage | 1 | 1.2% |
| (4) Persistence of uterine bleeding after evacuation | | | None | 12 | 14.1% | Up to 1 week | 60 | 70.6% | 2–3 weeks | 12 | 14.1% | ≥4 weeks | 1 | 1.2% |
| (5) Need for blood transfusion | 85 | 100% |
| (6) Fever | 22 | 25.8% |
| (7) Sepsis | 2 | 2.4% |
| (8) Respiratory insufficiency | 1 | 1.2% |
| (9) Postmolar trophoblastic disease | 2 | 2.4% |
| (10) Pattern of βhCG regression high risk group | | | Sharp regression | 66 | 94.3% | Slow regression | 2 | 2.9% | Plateau | 1 | 1.4% | Rising | 1 | 1.4% | Low risk group | | | Sharp regression | 3 | 20% | Slow regression | 12 | 80% |
|
|